Lowering the Diagnostic Threshold in Secondary Plasma Cell Leukemia? Comparison With Primary Cases and Implications for Flow Cytometry Immunophenotyping
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2025.100954 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Modern Pathology, 2026. Verfasst von Wen Shuai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Duke University Medical Center, Durham, North Carolina. Electronic address: wen.shuai@duke.edu. Hauptthemen laut MEDLINE: Flow Cytometry, Immunophenotyping, Leukemia, Plasma Cell, Plasma Cells. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
In 2021, the International Myeloma Working Group lowered the threshold to establish the diagnosis of primary plasma cell leukemia (pPCL) from ≥20% to ≥5% circulating plasma cells (CPCs) as assessed by morphologic evaluation (ME). However, the threshold for defining secondary PCL (sPCL) remains unclear. We retrospectively studied the clinicopathological features of 52 PCL patients, 30 pPCL and 22 sPCL, with ≥5% CPCs determined by either ME or flow cytometry immunophenotyping (FCI). FCI often revealed a higher percentage of CPCs than ME, likely due to difficulties in identifying morphologically abnormal plasma cells with certainty, and this discordance was statistically significant in sPCL patients. pPCL and sPCL both exhibited leukocytosis, thrombocytopenia, infrequent CD56 expression, high bone marrow tumor burden, and complex karyotypes. MYC rearrangement was observed only in sPCL cases. Paired cytogenetic data before and after leukemic transformation were available in a small subset of sPCL patients (8/22). Compared with the prior myeloma, sPCL more frequently harbored a complex karyotype, hypodiploidy, and additional cytogenetic abnormalities, most commonly gain of chromosome 1q. Using 5% CPCs as the diagnostic threshold, patients with sPCL had significantly poorer outcomes than patients with pPCL (P < .0001). Furthermore, the outcomes of sPCL patients with 5% to 19% CPCs were similarly poor as those patients with ≥20% CPCs (P = .4781), highlighting the need to recognize patients with ≥5% CPCs promptly. FCI appears to be a more sensitive method for this purpose in most cases. Using FCI, further studies are needed to determine whether a diagnostic threshold of 5% or lower may be used to establish the diagnosis of sPCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Duke University Medical Center, Durham, North Carolina. Electronic address: wen.shuai@duke.edu.
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: cyin@mdanderson.org.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Statistics, The University of Texas Health Science Center at Houston, Houston, Texas.
- Department of Pathology, The University of Texas Health Science Center at Houston, Houston, Texas.
Zitieren
APA
Shuai, W., Hu, Z., Yin, C. C., Chen, L., Wang, W., Tang, G., Sui, D., Li, S., Xu, J., Ibrahim, N., Pan, Z., You, M. J., Patel, K. P., Vega, F., Medeiros, L. J., & Lin, P. (2026). Lowering the Diagnostic Threshold in Secondary Plasma Cell Leukemia? Comparison With Primary Cases and Implications for Flow Cytometry Immunophenotyping. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100954
Vancouver
Shuai W, Hu Z, Yin CC, Chen L, Wang W, Tang G, et al. Lowering the Diagnostic Threshold in Secondary Plasma Cell Leukemia? Comparison With Primary Cases and Implications for Flow Cytometry Immunophenotyping. Modern Pathology. 2026. doi:10.1016/j.modpat.2025.100954
BibTeX
@article{Shuai2026,
author = {Shuai, Wen and Hu, Zhihong and Yin, C Cameron and Chen, Lei and Wang, Wei and Tang, Guilin and Sui, Dawen and Li, Shaoying and Xu, Jie and Ibrahim, Nourhan and Pan, Zenggang and You, M James and Patel, Keyur P and Vega, Francisco and Medeiros, L Jeffrey and Lin, Pei},
title = {Lowering the Diagnostic Threshold in Secondary Plasma Cell Leukemia? Comparison With Primary Cases and Implications for Flow Cytometry Immunophenotyping},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2025.100954}
}
EUVIMED